日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Biologically-informed integration of drug representations for breast cancer treatment using deep learning

利用深度学习进行生物学信息指导的药物表征整合，用于乳腺癌治疗

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-66384-6
Ge, Hewei; Mo, Hongnan; Wei, Yuhan; Wang, Jiani; Qi, Yalong; Li, Lixi; Ma, Fei
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer

一项多队列研究验证了脂质代谢和铁死亡相关指标在激素受体阳性乳腺癌预后和免疫治疗反应预测中的应用

期刊:International Journal of Biological Sciences
影响因子:10
doi:10.7150/ijbs.113213
Zeng, Cheng; Wang, Jiani; Zhao, Shen; Wei, Yuhan; Qi, Yalong; Liu, Shuning; Wang, Yuanyi; Ge, Hewei; Yang, Xiaoqi; Tan, Yujing; Jiang, Yizhou; Qian, Haili; Ma, Fei
肿瘤
肿瘤免疫
信号转导
乳腺癌
代谢
铁死亡
免疫/内分泌
发表日期：2025
文献求助 收藏

Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancer

预测晚期HER2阴性乳腺癌患者对PD-1免疫疗法反应的循环生物标志物

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70255
Wei, Yuhan; Ge, Hewei; Qi, Yalong; Zeng, Cheng; Sun, Xiaoying; Mo, Hongnan; Ma, Fei
肿瘤
HER2
肿瘤免疫
乳腺癌
PD-1
免疫/内分泌
发表日期：2025
文献求助 收藏

Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer.

基质PLAU介导肿瘤进展，并为三阴性乳腺癌提供了一种新的治疗靶点

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03867-y
Zou Jun, Zhang Jingyao, Li Yu, Yuan Baowen, Wang Yuanyi, Qi Yalong, Wang Qian, Qin Wan, Yuan Xianglin, Xu Binghe
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer

蒽环类药物与不含蒽环类药物的新辅助化疗免疫疗法方案治疗三阴性乳腺癌的疗效比较

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2024.102171
Wei, Yuhan; Li, Qiao; Mo, Hongnan; Qi, Yalong; Ge, Hewei; Sun, Xiaoying; Fan, Ying; Zhang, Pin; Wang, Jiayu; Luo, Yang; Wang, Jing; Ma, Fei
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Integrated bulk and single-cell transcriptomic analysis unveiled a novel cuproptosis-related lipid metabolism gene molecular pattern and a risk index for predicting prognosis and antitumor drug sensitivity in breast cancer

整合的细胞整体和单细胞转录组分析揭示了一种新的与铜凋亡相关的脂质代谢基因分子模式，以及一种用于预测乳腺癌预后和抗肿瘤药物敏感性的风险指数。

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02044-x
Zeng, Cheng; Xu, Chang; Liu, Shuning; Wang, Yuanyi; Wei, Yuhan; Qi, Yalong; Wang, Yue; Wang, Jiani; Ma, Fei
肿瘤
凋亡
表观遗传
肿瘤免疫
乳腺癌
代谢
细胞生物学
单细胞
发表日期：2025
文献求助 收藏

Novel Causal Evidence for the Role of Circulating Lipid Metabolites in Breast Cancer Risk: A Bidirectional Mendelian Randomization Analysis

循环脂质代谢物在乳腺癌风险中作用的新因果证据：双向孟德尔随机化分析

期刊:Journal of Nutrition and Metabolism
影响因子:2.4
doi:10.1155/jnme/2292774
Zeng, Cheng; Liu, Shuning; Wei, Yuhan; Qi, Yalong; Tan, Yujing; Qian, Haili; Wang, Jiani; Ma, Fei
肿瘤
肿瘤免疫
乳腺癌
代谢
发表日期：2025
文献求助 收藏

Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population-Based Large Cohort Study

对于新辅助化疗无反应的乳腺癌患者，可免除辅助化疗：一项基于人群的大型队列研究

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.70069
Li, Lixi; Zhang, Di; Liu, Shuning; Zeng, Cheng; Qi, Yalong; Ma, Fei
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Genetic factors in the pathogenesis of cardio-oncology

遗传因素在心脏肿瘤发病机制中的作用

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-05537-5
Qi, Yalong; Wei, Yuhan; Li, Lixi; Ge, Hewei; Wang, Yuanyi; Zeng, Cheng; Ma, Fei
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population

中国人群中，中性粒细胞与淋巴细胞比值升高与接受PD-1抑制剂或化疗的黑色素瘤患者预后不良相关

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2020.01752
Qi, Yalong; Liao, Daixiang; Mei, Dinglian; Zhang, Yong; Liu, Yang
细胞生物学
粒细胞
中性粒细胞
黑色素瘤
PD-1
发表日期：2020
文献求助 收藏